AI-powered phenotype–target coupled screening offers new path for herbal drug discovery
Peer-Reviewed Publication
Updates every hour. Last Updated: 5-Jun-2026 17:16 ET (5-Jun-2026 21:16 GMT/UTC)
Chinese herbal medicines have given birth to many classic drugs, but their complex ingredients and unclear mechanisms slow new drug development. A new study in Engineering proposes phenotype–target coupled drug screening, combining phenotype-based and target-based discovery with AI, multiomics, and organ-on-chip models. This efficient framework helps locate active compounds, clarify targets, and boost success rates for herbal drug research and development.
Digital transformation and artificial intelligence (AI) in healthcare requires a range of safeguards and standards to work well, but new research from Flinders University provides support for effective AI systems to improve cardiovascular care.
The study examines how Clinical Decision Support Systems (CDSS) can transform cardiovascular disease management – a leading cause of death in Australia – by providing more accurate, timely decisions while addressing real-world barriers like workflow integration, usability and clinician adoption.
The American Heart Association is investing in early-stage health innovators and collegiate entrepreneurs working to build solutions designed for adoption, trust, and measurable impact - 2026 EmPOWERED to Serve Business Accelerator™.